Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma

Romane Durand, Céline Bellanger, Charlotte Kervoëlen, Benoit Tessoulin, Christelle Dousset, Emmanuelle Menoret, Hélène Asnagli, Andrew Parker, Philip Beer, Catherine Pellat-Deceunynck, David Chiron

Open source

DOI
10.3324/haematol.2023.284345
Published
2024-02-22
Container
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2023.284345,
  title = {Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma},
  author = {Romane Durand and Céline Bellanger and Charlotte Kervoëlen and Benoit Tessoulin and Christelle Dousset and Emmanuelle Menoret and Hélène Asnagli and Andrew Parker and Philip Beer and Catherine Pellat-Deceunynck and David Chiron},
  year = {2024},
  journal = {Haematologica},
  doi = {10.3324/haematol.2023.284345},
  url = {https://doi.org/10.3324/haematol.2023.284345}
}

RIS

TY  - JOUR
TI  - Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma
AU  - Romane Durand
AU  - Céline Bellanger
AU  - Charlotte Kervoëlen
AU  - Benoit Tessoulin
AU  - Christelle Dousset
AU  - Emmanuelle Menoret
AU  - Hélène Asnagli
AU  - Andrew Parker
AU  - Philip Beer
AU  - Catherine Pellat-Deceunynck
AU  - David Chiron
PY  - 2024
JO  - Haematologica
DO  - 10.3324/haematol.2023.284345
UR  - https://doi.org/10.3324/haematol.2023.284345
ER  - 

APA

Durand, R., Bellanger, C., Kervoëlen, C., Tessoulin, B., Dousset, C., Menoret, E., Asnagli, H., Parker, A., Beer, P., Pellat-Deceunynck, C., & Chiron, D. (2024). Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma. Haematologica. https://doi.org/10.3324/haematol.2023.284345

Source records